Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-11-25

FDA Approved: DIVALPROEX SODIUM — Original Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved Bionpharma's original application for divalproex sodium, making a generic version available for epilepsy, bipolar disorder, and migraine prophylaxi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIVALPROEX SODIUM (divalproex sodium)

Snippet

ORIG AP for DIVALPROEX SODIUM (DIVALPROEX SODIUM)